Showing 2,392 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Drug-resistant TB

WHO Recommends Worldwide Adoption Of All Oral-Regimen For MDR/RR-TB

Editor's pick
Health Policy Watch
16 December 2019
PrEP science

Facebook ads push misinformation about HIV prevention drugs, LGBT activists say, ‘harming public health’

Editor's pick
Washington Post
10 December 2019
Resistance

WHO unveils plan to tackle rising HIV drug resistance in Africa

Editor's pick
World Health Organization
9 December 2019
Pharmaceutical industry

Gilead delayed safer HIV drug to extend monopoly profits, advocates allege

Editor's pick
San Francisco Chronicle
6 December 2019
New & experimental HIV treatments

ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
5 December 2019
Bad science & bogus treatments

China’s CRISPR babies: Read exclusive excerpts from the unseen original research

Editor's pick
MIT Technology Review
4 December 2019
Weight gain & lipodystrophy

New Formulation of Tesamorelin Available for HIV Patients With Lipodystrophy

Editor's pick
Infectious Disease Advisor
4 December 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
Changing treatment

Caveat emptor: Seven things every patient should know about switching from efavirenz to dolutegravir

Editor's pick
Spotlight
25 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
Drug interactions & pharmacokinetics

Polypharmacy: What Is It? And How Does It Affect People With HIV?

Editor's pick
TheBodyPro
20 November 2019
Bad science & bogus treatments

Retraction: Questioning the HIV-AIDS hypothesis: 30 years of dissent

Editor's pick
Frontiers in Public Health
18 November 2019
Bad science & bogus treatments

Another case of HIV cure hype-atitis

Editor's pick
HIV Cure
13 November 2019
Treatment simplification strategies

Jitters Over New Two-Drug HIV Regimens

Editor's pick
Medscape (requires free registration)
12 November 2019
HIV treatment

Biktarvy Maintains High Efficacy for Three Years in Clinical Trials

Editor's pick
POZ
11 November 2019
Bad science & bogus treatments

Gene Therapy and 'Cure': Tone It Down!

Editor's pick
Science
11 November 2019
Bad science & bogus treatments

Misleading Ads About PrEP Are Threatening Progress to End the HIV Epidemic. They Must Be Removed.

Editor's pick
TheBodyPro
7 November 2019
Resistance

FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations

Editor's pick
Food & Drug Administration
6 November 2019
HIV treatment

Learning the Names of HIV Drugs Is Horribly Difficult — Here’s Why

Editor's pick
HIV and ID Observations
4 November 2019
Women

Women and HIV in the United Kingdom

Editor's pick
Public Health England
2 November 2019
Side effects

Updated Labeling for Efavirenz-Containing Products Warns of Possible Late-Onset Neurotoxicity

Editor's pick
Monthly Prescribing Reference
31 October 2019
Cardiovascular disease

Delaying HIV Treatment Linked to Stiffened Blood Vessels

Editor's pick
POZ
30 October 2019
Treatment interruptions

Pausing the pills: attitudes to treatment interruption

Editor's pick
HIV Cure
28 October 2019